| Product NDC: | 55390-226 |
| Proprietary Name: | Amikacin Sulfate |
| Non Proprietary Name: | Amikacin Sulfate |
| Active Ingredient(s): | 250 mg/mL & nbsp; Amikacin Sulfate |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55390-226 |
| Labeler Name: | Bedford Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA063315 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19940531 |
| Package NDC: | 55390-226-04 |
| Package Description: | 10 VIAL in 1 BOX (55390-226-04) > 4 mL in 1 VIAL |
| NDC Code | 55390-226-04 |
| Proprietary Name | Amikacin Sulfate |
| Package Description | 10 VIAL in 1 BOX (55390-226-04) > 4 mL in 1 VIAL |
| Product NDC | 55390-226 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Amikacin Sulfate |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 19940531 |
| Marketing Category Name | ANDA |
| Labeler Name | Bedford Laboratories |
| Substance Name | AMIKACIN SULFATE |
| Strength Number | 250 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient] |